Clinical Trial Update: A Phase II Study of Triple-negative Breast Cancer Brain Metastases. [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating treatment for brain metastases in patients with triple-negative breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Triple-negative Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING